Prenatal Account Manager, Utah
Job Description
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives?
BillionToOne, ranked at the top 5% of Y Combinator companies with $300M+ in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly screen an unborn baby and assess its risk for common and severe recessive gene disorders and chromosomal abnormalities, as well as fetal sex and fetal antigens, from a single tube of blood from the pregnant mother without paternal testing.
In 2023, BillionToOne launched two liquid biopsy products that will markedly improve oncology treatment and care. With Northstar Select™, clinicians will be able to select cancer therapies that will be most effective to each patient based on their individual genetic makeup. Northstar Response™ will enable clinicians to monitor a ...
The Real Dill ☘️
DNA sequencing and genetic testing is nothing new, but BillionToOne is taking it one step further performing molecular diagnostics at an incredibly specific level. One of their products, UNITY Fetal Risk Screen, accurately assesses fetal risk for common autosomal recessive conditions without requiring a blood sample from the male partner...that was 96% sensitive for identifying a fetus as high risk across a sample size of over 40,000 patients. Early identification is key for disease management, and by being able to provide direct fetal insights into prevalent autosomal recessive conditions such as Cystic Fibrosis, Spinal Muscular Atrophy, and Alpha and Beta Hemoglobinopathies (including Sickle Cell Disease), more time for better clinical decisioning can occur. Science is amazing. (November 2023)
Jon Lee, PT, DPT, OCS, FAAOMPT, MBA
Pickle co-founder
About BillionToOne
Precision diagnostic that accurately counts DNA molecules at a single count level to diagnose disease
MissionTo remove the fear of the unknown by providing molecular diagnostics that are accurate, fast, and accessible.
Wow FactorDeveloped a non-invasive prenatal test (NIPT) that assesses fetal risk for recessive conditions and red blood cell antigen incompatibility
Company benefits
- 🐣 Maternity/paternity leave
- 🏦 401K/retirement
Pickle is not affiliated with listed companies unless otherwise noted.
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond
